Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Significant Decrease in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWYGet Free Report) saw a significant decrease in short interest in the month of June. As of June 15th, there was short interest totaling 1,023 shares, a decrease of 63.1% from the May 31st total of 2,772 shares. Based on an average daily trading volume, of 7,852 shares, the short-interest ratio is currently 0.1 days.

Carl Zeiss Meditec Trading Down 2.4%

CZMWY opened at $30.98 on Friday. Carl Zeiss Meditec has a twelve month low of $26.65 and a twelve month high of $67.53. The company has a fifty day moving average of $30.41 and a 200-day moving average of $34.30.

Analyst Upgrades and Downgrades

Separately, Zacks Research lowered Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research note on Monday, May 25th. One equities research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Carl Zeiss Meditec has a consensus rating of “Hold”.

View Our Latest Analysis on CZMWY

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.

Recommended Stories

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.